Brazil's National Health Surveillance Agency (Anvisa) has approved the drug Awiqli, produced by the pharmaceutical company ...

Awiqli has been cleared for both types of diabetes in all its current markets except China, where it can be used for type 2 only. “We believe in the potential of once-weekly basal insulin icodec ...

The report – which can be viewed here – highlights the following new medicines: 1) Novo Nordisk's Awiqli (LAI 287; insulin icodec), a long-acting basal insulin analogue for type 1 and type 2 ...